MBRX News and Press, Moleculin Biotech Inc. From 07/06/23

Moleculin to Participate in the Virtual Investor Summer Spotlight Series PR Newswire Live moderated video webcast on Wednesday, July 12 th at 3:00 PM ET HOUSTON , July 6, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ...

Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest PR Newswire Live webcast fireside chat on Wednesday, June 21 st at 1:30 PM ET HOUSTON , June 13, 2023 /PRNewswire/ -- Moleculin...

Moleculin Announces Adjournment of 2023 Annual Meeting to June 15, 2023 PR Newswire - Company urges shareholders of record date, March 27, 2023 , to vote your shares immediately if you have not already done so HOUSTON , May 30, 2023 /PRNewswire/ -- Moleculi...

2023-05-11 11:29:10 ET Moleculin Biotech, Inc. (MBRX) Q1 2023 Earnings Conference Call May 11, 2023 8:30 a.m. ET Company Participants Jenene Thomas - Investor Relations Walter Klemp - Chairman and Chief Executive Officer John Paul Waymack - Senior Chief Medical O...

2023-05-11 07:08:35 ET Moleculin Biotech press release ( NASDAQ: MBRX ): Q1 GAAP EPS of -$0.28 in-line. As of March 31, 2023, the Company had cash and cash equivalents of $37.3 million and believes that this cash is sufficient to meet its projected operating requirements i...

Moleculin Reports First Quarter 2023 Financial Results PR Newswire – Continued clinical and operational execution across ongoing development programs with growing body of positive preclinical and clinical data – Sufficient capital to fund operat...

Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones PR Newswire – Actively recruiting in three Phase 1b /2 clinical trials (one of which is in Phase 2) – Recently completed first cohort in Phase 1b /2 tri...

2023-05-10 11:12:09 ET Major earning expected before the bell on Thursday include: Fiverr International ( FVRR ) Himax Technologies ( HIMX ) JD.com ( JD ) Marathon Digital Holdings ( MARA ) Tapestry ( TPR ) For further details see: Notable...

Moleculin to Report First Quarter Financial Results on May 11, 2023 and Host Conference Call and Webcast PR Newswire HOUSTON , May 4, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical...

Moleculin Successfully Completes First Cohort in Phase 1b/2 Trial Evaluating Annamycin in Combination with Cytarabine (Ara-C) for the Treatment of Acute Myeloid Leukemia (AML) PR Newswire Preliminary results demonstrate a durable complete response at starting dose level in eld...